[關(guān)鍵詞]
[摘要]
為了解中藥重樓的研究現(xiàn)狀、未來發(fā)展趨勢,以“重樓”“Paris polyphylla”為關(guān)鍵詞,檢索中國期刊全文數(shù)據(jù)庫(CNKI)、萬方數(shù)據(jù)庫、Web of Science(WOS)、PubMed等數(shù)據(jù)庫2000年1月1日—2022年6月4日發(fā)表的有關(guān)重樓研究的文獻,使用Cite Space、VOS viewer軟件轉(zhuǎn)換數(shù)據(jù),從文獻計量學(xué)角度進行分析并構(gòu)建出有關(guān)研究的可視化圖譜,分別構(gòu)建“重樓”研究的文獻關(guān)鍵詞的熱點。結(jié)果發(fā)現(xiàn)限制重樓發(fā)展的3個問題以及對《中國藥典》重樓規(guī)范化提出建議,并對相關(guān)行業(yè)標(biāo)準(zhǔn)的制定提供一定參考。
[Key word]
[Abstract]
To study the research status, progress and future research trends and other issues of traditional Chinese medicine Paris polyphylla, and provide convenient data reference basis and relevant suggestions for follow-up heavy research, literatures were retrieved from CNKI, Wanfang Data, Web of Science (WOS) and PubMed from January 1, 2000 to June 4, 2022 with the key words "Paris Polyphylla". Cite Space and VOS viewer were used to construct visual atlas of hot spot analysis of keywords research respectively, the relevant knowledge map of Paris Polyphylla was analyzed and constructed for visual analysis. Three problems restricting the development of Paris Polyphylla, two perspectives of Paris Polyphylla industry need to be improved, and two suggestions on standardization of Paris Polyphylla proposed by Chinese Pharmacopoeia were found. The prospect of future research on Paris Polyphylla was put forward, which provides some reference for the formulation of relevant industry standards.
[中圖分類號]
R282.7
[基金項目]
國家自然科學(xué)基金資助項目(82204552);中國博士后科學(xué)基金項目(2021M692893,2021M702927);浙江省自然科學(xué)基金項目(LQ22H280007);浙江省大學(xué)生新苗人才計劃(2022R410A026);浙江省中醫(yī)藥科技計劃中醫(yī)藥現(xiàn)代化專項(2021ZX008);浙江中醫(yī)藥大學(xué)科研項目(2022JKZKTS10);2022年大學(xué)生創(chuàng)新創(chuàng)業(yè)訓(xùn)練計劃(S202210344093,S202210344107)